Antimicrobial Stewardship Techniques for Critically Ill Patients with Pneumonia

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Clinical Microbiology

Background:

• Pneumonia affects 27% of intensive care unit (ICU) patients.
• Inappropriate antimicrobial use leads to resistance, Clostridiodes difficile infection, and toxicities.
• Optimizing antibiotic therapy in critically ill patients is essential.

Purpose of the Study:

• To review methods for optimizing antimicrobial therapy in ICU pneumonia.
• To highlight strategies for minimizing antimicrobial-related toxicities and resistance.
• To discuss the role of biomarkers and rapid diagnostics in treatment decisions.

Main Methods:

• Review of current literature and clinical guidelines.
• Discussion of procalcitonin utility in guiding antibiotic use.
• Evaluation of methicillin-resistant Staphylococcus aureus (MRSA) nares testing.
• Analysis of Biofire FilmArray pneumonia polymerase chain reaction (PCR) panel performance.
• Examination of microbiology reporting techniques.

Main Results:

• Procalcitonin can aid in de-escalating antibiotic therapy.
• MRSA nares testing helps determine the necessity of vancomycin.
• Rapid PCR diagnostics like Biofire FilmArray improve pathogen identification.
• Enhanced microbiology reporting facilitates timely and appropriate treatment.

Conclusions:

• Implementing these strategies can optimize antimicrobial use in ICU pneumonia.
• These methods aim to reduce antibiotic resistance and patient toxicity.
• A multi-faceted approach incorporating diagnostics and reporting is key to effective treatment.